https://journal.chestnet.org/article/S0012-3692(12)60129-9/pdf

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

https://www.healthcare.uiowa.edu/familymedicine/fpinfo/Docs/Chest%20Rx%20VTE%20Feb%202016.pdf

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(11)61753-4.pdf

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Chronic leg symptoms after deep venous thrombosis (DVT) (the postthrombotic syndrome) are common but difficult to predict. By using a standardized scale, Kahn and coworkers evaluated leg symptoms i...

Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2007.02788.x

Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2008.02998.x

Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence.

The risk of recurrent venous thromboembolism among patients with high factor IX levels.

We studied the incidence of leukemia cutis (LC) in 381 consecutive patients with acute myeloid leukemia (AML) in a single institution and compared the demographic, hematological, and cytogenetic findings in AML patients with and without LC. We also examined the response to intensive chemotherapy, overall survival, and duration of remission in this patient population with regard to the presence of LC. The prevalence of LC was 3.7% in clinically diagnosed patients and 2.9% in biopsy-proven cases, respectively. Patients with and without LC did not differ with regard to age, sex, white blood cell counts, hemoglobin, fibrinogen, and platelet counts at diagnosis, but lactate dehydrogenase (LDH) was significantly higher in patients with LC. Various karyotype abnormalities were found, but in patients with LC numerical abnormalities of chromosome 8 were significantly more common (P<0.0001). Patients with LC did not differ from patients without LC with regard to remission rate, but there was a trend towards shorter remission duration in patients with LC. We conclude that patients with LC have some features different from patients without this symptom. The increased frequency of numerical aberrations of chromosome 8 in patients with LC was the most interesting observation of our study. The pathophysiological significance of this finding remains to be determined.

A. Weltermann

Papers

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.

Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity

Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence.

The risk of recurrent venous thromboembolism among patients with high factor IX levels.

A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis